Mologen Appoints Walter Miller CFO
This article was originally published in Scrip
Immunology-focused biotech Mologen AG has appointed Walter Miller chief financial officer (CFO) and to its executive board – effective April 1, 2016. Miller has experience in working at start-ups and listed companies in Germany and abroad and most recently was CFO of Nuvisan GmbH. Prior to this he held various managerial positions at Santhera Pharmaceuticals Group.
Register for our free email digests: